Circulating Regulatory T-Cells in Monoclonal Gammopathies of Uncertain Significance and Multiple Myeloma: In Search of a Role

Figure 3

Percentage of inhibition of autologous CD4⁺CD25⁻ cells in healthy controls (CTRL) (71.6%  ± 3%), monoclonal gammopathy of uncertain significance (MGUS) (68.3%  ± 6%), smoldering multiple myeloma (SMM) (73.3%  ± 9.1%), and active multiple myeloma (MM) (72.5%  ± 9.9%) ( ns).